Amedisys [AMED] vs Encompass Health [EHC] Detailed Stock Comparison

Amedisys Inc.

NASDAQ
Loading...

Encompass Health Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Amedisys Inc. wins in 6 metrics, Encompass Health Corporation wins in 14 metrics, with 0 ties. Encompass Health Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Amedisys Inc. Encompass Health Corporation Better
P/E Ratio (TTM) 39.30 18.52 Encompass Health Corporation
Price-to-Book Ratio 2.69 4.21 Amedisys Inc.
Debt-to-Equity Ratio 35.34 82.85 Amedisys Inc.
PEG Ratio -2.78 0.89 Encompass Health Corporation
EV/EBITDA 13.74 9.92 Encompass Health Corporation
Profit Margin (TTM) 3.56% 9.54% Encompass Health Corporation
Operating Margin (TTM) 11.70% 18.35% Encompass Health Corporation
EBITDA Margin (TTM) 11.70% 18.35% Encompass Health Corporation
Return on Equity 6.67% 24.82% Encompass Health Corporation
Return on Assets (TTM) 6.52% 9.66% Encompass Health Corporation
Free Cash Flow (TTM) $214.29M $439.20M Encompass Health Corporation
Dividend Yield N/A 0.68% N/A
1-Year Return 2.68% -16.09% Amedisys Inc.
Price-to-Sales Ratio (TTM) 1.38 1.74 Amedisys Inc.
Enterprise Value $3.48B $13.70B Encompass Health Corporation
EV/Revenue Ratio 1.45 2.31 Amedisys Inc.
Gross Profit Margin (TTM) 43.96% 95.82% Encompass Health Corporation
Revenue per Share (TTM) $73 $59 Amedisys Inc.
Earnings per Share (Diluted) $2.57 $5.55 Encompass Health Corporation
Beta (Stock Volatility) 0.90 0.60 Encompass Health Corporation
Short % of Float 9.90% 3.81% Encompass Health Corporation

Amedisys Inc. vs Encompass Health Corporation Stock Performance Analysis

Loading Price Chart...

AMED
EHC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Amedisys Inc.0.00%0.05%3.57%7.76%10.13%10.13%
Encompass Health Corporation-2.08%-1.73%-6.83%-2.04%-7.65%-6.59%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Amedisys Inc.2.68%-14.45%-58.43%149.36%328.29%215.59%
Encompass Health Corporation-16.09%55.92%60.05%221.72%399.85%545.89%

Performance & Financial Health Analysis: Amedisys Inc. vs Encompass Health Corporation

MetricAMEDEHC
Market Information
Market Cap i$3.32B$10.25B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i1,027,642858,260
90 Day Avg. Volume i618,767939,637
Last Close$100.99$99.36
52 Week Range$82.15 - $101.02$92.77 - $127.99
% from 52W High-0.03%-22.37%
All-Time High$325.12 (Jan 25, 2021)$127.99 (Oct 24, 2025)
% from All-Time High-68.94%-22.37%
Growth Metrics
Quarterly Revenue Growth0.05%0.10%
Quarterly Earnings Growth-0.13%0.21%
Financial Health
Profit Margin (TTM) i0.04%0.10%
Operating Margin (TTM) i0.12%0.18%
Return on Equity (TTM) i0.07%0.25%
Debt to Equity (MRQ) i35.3482.85
Cash & Liquidity
Book Value per Share (MRQ)$37.48$24.38
Cash per Share (MRQ)$10.26$0.73
Operating Cash Flow (TTM) i$239.42M$1.18B
Levered Free Cash Flow (TTM) i$300.69M$296.79M
Dividends
Last 12-Month Dividend Yield iN/A0.68%
Last 12-Month Dividend iN/A$0.72

Valuation & Enterprise Metrics Analysis: Amedisys Inc. vs Encompass Health Corporation

MetricAMED (Aug 31, 2025)EHC (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i39.3018.52
Forward P/E i19.7615.86
PEG Ratio i-2.780.89
Price to Sales (TTM) i1.381.74
Price to Book (MRQ) i2.694.21
Market Capitalization
Market Capitalization i$3.32B$10.25B
Enterprise Value i$3.48B$13.70B
Enterprise Value Metrics
Enterprise to Revenue i1.452.31
Enterprise to EBITDA i13.749.92
Risk & Other Metrics
Beta i0.900.60
Book Value per Share (MRQ) i$37.48$24.38

Financial Statements Comparison: Amedisys Inc. vs Encompass Health Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAMED (2024)EHC (2025)
Revenue/Sales i2.35B5.94B
Cost of Goods Sold i1.33B254.40M
COGS % of Revenue i56.7%4.3%
Gross Profit i1.02B5.68B
Gross Margin i43.3%95.7%
Research & Development iN/AN/A
Operating Income (EBIT) i209.57M1.05B
Operating Margin i8.9%17.7%
EBITDA i292.47M1.40B
EBITDA Margin i12.5%23.7%
Pre-Tax Income i86.22M953.00M
Pre-Tax Income % of Revenue i3.7%16.1%
Income Tax i48.05M192.90M
Income Tax % of Revenue i2.0%3.3%
Net Income (Profit) i38.16M759.10M
Profit Margin i1.6%12.8%

Balance Sheet & Liquidity Metrics

MetricAMED (2024)EHC (2025)
Cash & Equivalents i303.24M72.20M
Total Current Assets i632.08M905.90M
Total Current Assets % of Revenue i26.9%15.3%
Total Current Liabilities i514.39M836.40M
Total Current Liabilities % of Revenue i21.9%14.1%
Long-Term Debt i395.42M2.64B
Long-Term Debt % of Revenue i16.8%44.5%
Total Shareholders Equity i1.18B3.28B
Retained Earnings i791.16M1.29B
Retained Earnings % of Revenue i33.7%21.7%
Property, Plant & Equipment i167.80M212.60M

Cash Flow Statement Comparison

MetricAMED (2024)EHC (2025)
Operating Cash Flow i144.50M1.19B
Operating Cash Flow % of Revenue i6.2%20.1%
Capital Expenditures i-6.55M-736.40M
Free Cash Flow i214.29M439.20M
FCF Margin i9.1%7.4%
Debt Repayment i0-239.00M
Common Stock Repurchase i-6.15M-158.00M

Short Interest & Institutional Ownership Analysis

MetricAMEDEHC
Shares Short i3.20M3.36M
Short Ratio i6.843.73
Short % of Float i9.90%3.81%
Shares Outstanding i32.78M100.00M
Float Shares i32.24M98.16M
% Held by Insiders i1.95%1.05%
% Held by Institutions i96.37%102.10%
% Held by Public i1.68%-3.15%

Dividend Analysis & Yield Comparison: Amedisys Inc. vs Encompass Health Corporation

MetricAMEDEHC
Last 12-Month Dividend iN/A$0.72
Last 12-Month Dividend Yield iN/A0.68%
3-Year Avg Annual Dividend iN/A$0.65
3-Year Avg Dividend Yield iN/A0.19%
3-Year Total Dividends iN/A$1.96
Ex-Dividend DateN/AJan 02, 2026